Medtronic will distribute Viz.ai’s artificial intelligence system for detection and triage of large vessel occlusions in the US alongside Medtronic's Solitaire stent-retrievers for revascularization of occluded blood vessels in the brain.
Medtronic PLC has agreed to distribute Viz.ai Inc.’s artificial intelligence system for detection and triage of large vessel brain occlusion (LVO) strokes alongside its Solitaire stent retrievers, the companies announced July 22.
Viz.ai’s technology uses advanced artificial intelligence to identify suspected LVO strokes based on data from computed tomography (CT) data. It...
The ceramic device, designed to reduce complications, will be exclusively distributed by Zimmer Biomet and initially available in 30 hospitals, with broader European access expected by 2026.
Medtronic beat first-quarter revenue and EPS estimates, raised guidance, and added two board members and special committees as Elliott takes a stake.
Entrepreneurialism is in the blood of Israel’s medtech innovators, but in a changing medtech world, the local ecosystem must address funding gaps and manufacturing and infrastructure needs. So says Ruti Alon, experienced Israeli medtech leader, investor and co-chair of the Biomed Israel conference.
Luna Health has raised $23.6m in Series A funding to support regulatory submissions, clinical studies and manufacturing for its insulin patch pump.
A Japanese study of Watchman LAA closure devices found that leaks of any size after implantation raise the risk of stroke. The study comes shortly after the US FDA issued an early alert for the Watchman access systems.
A late-August batch of device classifications from the US FDA includes genetic tests from 23andMe, hand-held spinal surgery tools, and several IVDs.
Amendments to Germany’s – barely in force – health reform law will be decided after the summer break. The new DRGs payments plan and service groups will be reviewed, but critics fear for the law’s future.
